• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Kevin R. Loughlin, MD


  • Loughlin KR.Calcium channel blockers and prostate cancer.Urol Oncol. 2014 May 7.
  • Loughlin KR.The hedgehog pathway: Potential biomarker and therapeutic applications in urologic malignancies.Urol Oncol. 2014 May 7.
  • Prasad SM, Eyre S, Loughlin KR.Salvage combination intravesical immunotherapy with bacillus calmette-guérin and interferon-α2B: impact on recurrence, progression, and survival.Hosp Pract (Minneap). 2013 Oct;41(4):31-9.
  • Loughlin KR.Re: Potential years of life lost due to urogenital cancer in the United States: trends from 1972 to 2006 based on data from the SEER database: M. H. Kamel, P. C. Moore, N. K. Bissada and S. M. Heshmat. J Urol 2012; 187: 868-871.J Urol. 2012 Sep;188(3):1049; author reply 1050.
  • Loughlin KR.The practice of urologic oncology: some economic realties.Urol Oncol.;30(4 Suppl):S5-9.
  • Loughlin KR.The future of urologic cancer care in the United States: our finest hour or a bridge too far.Urol Oncol.;28(6):581-4.
  • Loughlin KR, Prasad MM.Post-prostatectomy urinary incontinence: a confluence of 3 factors.J Urol. 2010 Mar;183(3):871-7. Review.
  • Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Howe RJ, Lange PH, Lilja H, Loughlin KR, Mohler J, Moul J, Nadler RB, Patterson SG, Presti JC, Stroup AM, Wake R, Wei JT.NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection.J Natl Compr Canc Netw. 2010 Feb;8(2):240-62.
  • Loughlin KR.Presidential operations.J Am Coll Surg. 2009 Dec;209(6):796-7.
  • Fernández CA, Wszolek MF, Loughlin KR, Libertino JA, Summerhayes IC, Shuber AP.A novel approach to using matrix metalloproteinases for bladder cancer.J Urol. 2009 Nov;182(5):2188-94.
  • Loughlin KR.Hypoxia inducible factor (HIF): Its central role in renal cell cancer targeted therapy.Urol Oncol. 2009 May-Jun;27(3):236-7.
  • Loughlin KR.Renal cancer: Genetic directed therapy.Urol Oncol. 2009 Mar-Apr;27(2):130.
  • Bassett WW,Bettendorf DM,Lewis JM,Loughlin KR.Chronic periglandular inflammation on prostate needle biopsy does not increase the likelihood of cancer on subsequent biopsy.Urology. 2009 Apr;73(4):845-9.
  • Zinner MJ,Loughlin KR.The evolution of health care in America.Urol Clin North Am. 2009 Feb;36(1):1-10, v.
  • Loughlin KR.Medical malpractice: the good, the bad, and the ugly.Urol Clin North Am. 2009 Feb;36(1):101-10, vii.
  • Loughlin KR.Immunotherapy: a new paradigm for androgen-refractory prostate cancer.Urol Oncol. 2008 Nov-Dec;26(6):575.
  • Loughlin KR.Re: Medical malpractice in American urology: 22-year national review of the impact of caps and implications for contemporary practice: M. H. Hsieh, A. G. Tan and M. V. Meng J Urol 2008; 179: 1944-1949.J Urol. 2008 Dec;180(6):2720-1; author reply 2721.
  • Roy R,Louis G,Loughlin KR,Wiederschain D,Kilroy SM,Lamb CC,Zurakowski D,Moses MA.Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.Clin Cancer Res. 2008 Oct 15;14(20):6610-7.
  • Loughlin KR.Understanding intravesical BCG: A window to the future treatment of noninvasive bladder cancer.Urol Oncol. 2008 Jul-Aug;26(4):339-40.
  • Hong YM, Loughlin KR.Economic impact of tumor markers in bladder cancer surveillance.Urology. 2008 Jan;71(1):131-5. Review.
  • Loughlin KR.The current status of medical student urological education in the United States.J Urol. 2008 Mar;179(3):1087-90; discussion 1090-1.
  • Loughlin KR, Ganatra A.Re: Malignant ureteral obstruction: outcomes after intervention. Have things changed? L. M. Wong, L. K. Cleeve, A. D. Milner and A. G. Pitman. J Urol 2007; 178: 178-183.J Urol. 2008 Jan;179(1):386.
  • Zhang JQ, Loughlin KR, Zou KH, Haker S, Tempany CM.Role of endorectal coil magnetic resonance imaging in treatment of patients with prostate cancer and in determining radical prostatectomy surgical margin status: report of a single surgeon's practice.Urology. 2007 Jun;69(6):1134-7.
  • Silletti JP, Gordon GJ, Bueno R, Jaklitsch M, Loughlin KR.Prostate biopsy: past, present, and future.Urology. 2007 Mar;69(3):413-6.
  • Duque JL, Loughlin KR, Adam RM, Kantoff P, Mazzucchi E, Freeman MR.Measurement of plasma levels of vascular endothelial growth factor in prostate cancer patients: relationship with clinical stage, Gleason score, prostate volume, and serum prostate-specific antigen.Clinics. 2006 Oct;61(5):401-8.
  • Bueno R, Loughlin KR, Powell MH, Gordon GJ.A diagnostic test for prostate cancer from gene expression profiling data.J Urol. 2004 Feb;171(2 Pt 1):903-6.
  • Fielding JR, Hoyte LX, Okon SA, Schreyer A, Lee J, Zou KH, Warfield S, Richie JP, Loughlin KR, O'Leary MP, Doyle CJ, Kikinis R.Tumor detection by virtual cystoscopy with color mapping of bladder wall thickness.J Urol. 2002 Feb;167(2 Pt 1):559-62.
  • Gaston SM, Loughlin KR.Now what do we do with all these genes? Yeast-based two-hybrid analysis: an emerging technology for molecular urology in the post-genome era.Urology. 1999 Apr;53(4):835-42.
  • D'Amico AV, Desjardin A, Chen MH, Paik S, Schultz D, Renshaw AA, Loughlin KR, Richie JP.Analyzing outcome-based staging for clinically localized adenocarcinoma of the prostate.Cancer. 1998 Nov 15;83(10):2172-80.
  • Duque JL, Loughlin KR, O'Leary MP, Kumar S, Richie JP.Partial nephrectomy: alternative treatment for selected patients with renal cell carcinoma.Urology. 1998 Oct;52(4):584-90.
  • Renshaw AA, Richie JP, Loughlin KR, Jiroutek M, Chung A, D'Amico AV.The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens.Cancer. 1998 Aug 15;83(4):748-52.
  • Moses MA, Wiederschain D, Loughlin KR, Zurakowski D, Lamb CC, Freeman MR.Increased incidence of matrix metalloproteinases in urine of cancer patients.Cancer Res. 1998 Apr 1;58(7):1395-9.
  • Poteat HT, Ho GT, Lee ML, Welch WR, Loughlin KR, Sacks DB.The utility of patient age in evaluating prostate cancer.Am J Clin Pathol. 1997 Mar;107(3):337-44.
  • Goldstein DS, Lu ML, Hattori T, Ratliff TL, Loughlin KR, Kavoussi LR.Inhibition of peritoneal tumor-cell implantation: model for laparoscopic cancer surgery.J Endourol. 1993 Jun;7(3):237-41.